MAPT and Alzheimer disease: Thus, in APOE4 homozygotes with BCHE-K with mild AD below the age of 75 years, increases in tau pathology first appear in the MTL and these increases are dependent on removal or denervation of the corticolimbic cholinergic “brake” on glial activation.